EMA
approval
· 2006-06-06
European Medicines Agency adopts a positive opinion for the use of Prozac in the treatment of children and adolescents suffering from depression
Summary
EMA adopts a positive opinion for using Prozac (fluoxetine) to treat depression in children and adolescents, indicating potential authorization for this age gro…
Upgrade for the full analysis, importance score, and drug timeline.